Merck (MRK) volatility flat into upgrade to Buy at Citigroup
Tweet
Share
E-mailGet Alerts MRK Hot Sheet
Join SI Premium – FREE
Merck (NYSE: MRK) overall option implied volatility of 17 is near its 26-week average according to Track Data, suggesting non-directional price movement into an upgraded to Buy from Neutral at Citigroup.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Guggenheim Reiterates Buy Rating on Merck (MRK)
- Intel (INTC) call put ratio 1.2 calls to 1 put as share price down 3.3%
- FDA approves Merck's Lipfendra as first oral PCSK9 inhibitor
Create E-mail Alert Related Categories
OptionsRelated Entities
Citi, OptionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
